Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
about
MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell linesNovel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients.The biomarker landscape in mycosis fungoides and Sézary syndrome.Genomic landscape of cutaneous T cell lymphoma.Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progressionONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
P2860
Q34545956-5307E13A-43D6-4468-94E0-ED14F6429C9FQ36187589-C0E9B6D7-8DA2-479F-863D-FE684B7B821FQ36844207-AAF62C44-162B-4873-9C34-15AC5CCDAB62Q36890779-CDF092A8-CAE8-45A7-8651-162DF1BF9350Q39023382-FE2AC25C-74C8-401B-91A5-BC112C68D2E5Q42027899-649F6D30-366C-4832-9D43-1F681FCDCED1Q42039131-0699F6E4-7DE4-42F1-9E91-79FB91D2EB54Q42365296-2C796F35-57D6-41B6-A4B8-7B0920CB465BQ47359072-EE70AF08-2FDA-42CF-9194-3B1FE2D33D2E
P2860
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@ast
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@nl
type
label
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@ast
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@nl
prefLabel
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@ast
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@nl
P1433
P1476
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
P2093
P407
P577
2013-09-01T00:00:00Z